Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

NCT05831449 is registered in ClinicalTrials.gov with Cali Pharmaceuticals LLC as lead sponsor.

NCT NCT05831449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05831449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy
Lead sponsor
Cali Pharmaceuticals LLC
Phase
Phase 3
Overall status
Completed
Start date
May 22, 2023
Completion date
October 6, 2025
Enrollment
616 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bunion, post-operative pain